101 related articles for article (PubMed ID: 10617685)
1. In vivo signal transduction of nociceptive response by kyotorphin (tyrosine-arginine) through Galpha(i)- and inositol trisphosphate-mediated Ca(2+) influx.
Ueda H; Inoue M
Mol Pharmacol; 2000 Jan; 57(1):108-15. PubMed ID: 10617685
[TBL] [Abstract][Full Text] [Related]
2. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor.
Sugawara H; Kurosaki M; Takata M; Kurosaki T
EMBO J; 1997 Jun; 16(11):3078-88. PubMed ID: 9214625
[TBL] [Abstract][Full Text] [Related]
3. Fertilization and inositol 1,4,5-trisphosphate (IP3)-induced calcium release in type-1 inositol 1,4,5-trisphosphate receptor down-regulated bovine eggs.
Malcuit C; Knott JG; He C; Wainwright T; Parys JB; Robl JM; Fissore RA
Biol Reprod; 2005 Jul; 73(1):2-13. PubMed ID: 15744020
[TBL] [Abstract][Full Text] [Related]
4. Xestospongin C, a novel blocker of IP3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells.
Oka T; Sato K; Hori M; Ozaki H; Karaki H
Br J Pharmacol; 2002 Apr; 135(8):1959-66. PubMed ID: 11959799
[TBL] [Abstract][Full Text] [Related]
5. IP3 receptor-operated calcium entry.
Mikoshiba K; Hattori M
Sci STKE; 2000 Sep; 2000(51):pe1. PubMed ID: 11752610
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic neurosteroid/sigma-receptor involved in stimulation of nociceptor endings of mice.
Ueda H; Inoue M; Yoshida A; Mizuno K; Yamamoto H; Maruo J; Matsuno K; Mita S
J Pharmacol Exp Ther; 2001 Aug; 298(2):703-10. PubMed ID: 11454934
[TBL] [Abstract][Full Text] [Related]
7. Odorant receptors directly activate phospholipase C/inositol-1,4,5-trisphosphate coupled to calcium influx in Odora cells.
Liu G; Badeau RM; Tanimura A; Talamo BR
J Neurochem; 2006 Mar; 96(6):1591-605. PubMed ID: 16539682
[TBL] [Abstract][Full Text] [Related]
8. Mini-dystrophin expression down-regulates overactivation of G protein-mediated IP3 signaling pathway in dystrophin-deficient muscle cells.
Balghi H; Sebille S; Constantin B; Patri S; Thoreau V; Mondin L; Mok E; Kitzis A; Raymond G; Cognard C
J Gen Physiol; 2006 Feb; 127(2):171-82. PubMed ID: 16446505
[TBL] [Abstract][Full Text] [Related]
9. Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation.
Cárdenas C; Liberona JL; Molgó J; Colasante C; Mignery GA; Jaimovich E
J Cell Sci; 2005 Jul; 118(Pt 14):3131-40. PubMed ID: 16014380
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of inositol 1,4,5-trisphosphate receptor type 1 and type 3 by ATP.
Maes K; Missiaen L; De Smet P; Vanlingen S; Callewaert G; Parys JB; De Smedt H
Cell Calcium; 2000 May; 27(5):257-67. PubMed ID: 10859592
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of the green fluorescent protein-tagged inositol 1,4,5-trisphosphate receptor type 3 in Ca(2+) release and entry in DT40 B lymphocytes.
Morita T; Tanimura A; Nezu A; Kurosaki T; Tojyo Y
Biochem J; 2004 Sep; 382(Pt 3):793-801. PubMed ID: 15175012
[TBL] [Abstract][Full Text] [Related]
12. Activation of inositol 1,4,5-trisphosphate receptor is essential for the opening of mouse TRP5 channels.
Kanki H; Kinoshita M; Akaike A; Satoh M; Mori Y; Kaneko S
Mol Pharmacol; 2001 Nov; 60(5):989-98. PubMed ID: 11641427
[TBL] [Abstract][Full Text] [Related]
13. Inositol(1,4,5)trisphosphate signal triggers a receptor-mediated ATP release.
Katsuragi T; Sato C; Guangyuan L; Honda K
Biochem Biophys Res Commun; 2002 May; 293(2):686-90. PubMed ID: 12054523
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal Ca2+-independent calmodulin-binding site on the inositol 1,4,5-trisphosphate receptor is responsible for calmodulin inhibition, even though this inhibition requires Ca2+.
Kasri NN; Bultynck G; Smyth J; Szlufcik K; Parys JB; Callewaert G; Missiaen L; Fissore RA; Mikoshiba K; de Smedt H
Mol Pharmacol; 2004 Aug; 66(2):276-84. PubMed ID: 15266018
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the type III InsP(3) receptor by InsP(3) and calcium.
O'Neill AF; Hagar RE; Zipfel WR; Nathanson MH; Ehrlich BE
Biochem Biophys Res Commun; 2002 Jun; 294(3):719-25. PubMed ID: 12056830
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
18. Sorting of calcium signals at the junctions of endoplasmic reticulum and mitochondria.
Csordás G; Hajnóczky G
Cell Calcium; 2001 Apr; 29(4):249-62. PubMed ID: 11243933
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Ca2+ signaling in tachykinin-mediated contractile responses in swine trachea.
Lin YR; Kao PC; Chan MH
J Biomed Sci; 2005; 12(3):547-58. PubMed ID: 15971006
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
